The public media has been reporting the fraud and abuse of narcotic dispensed for pain. Reports target the legitimacy of prescriptions and pharmacist who fulfill them. Federal and state regulations have placed emphasis on corresponding responsibilities for the pharmacist who fulfills those prescriptions.
Today’s pharmacists will need to familiarize themselves with the stringent laws and regulations enforced by the Drug Enforcement Administration (DEA) through their Office of Diversion Control (Diversion). Since the focus of any DEA investigation is the legitimacy of a prescription, the initial targets are the physician who prescribed the prescription and the pharmacist who fulfilled the prescription.
The need to comply with a strict Due Diligence Policy by a pharmacist and the pharmacy staff is important to prevent the pharmacy from being the target of an investigation by DEA or any state law enforcement or regulatory entity.
Why Should you Attend:
This presentation talk about the extensive amount of information provided on DEA regulation requirements and the Due Diligence need for a pharmacy in order to prevent fraud and diversion of controlled substances dispensed through a prescription.
Objectives of the Presentation:
Class participants will familiarize themselves with DEA regulations for Schedules II controlled substances dispensed in a pharmacy setting and the criteria for developing a Due Diligence Policy in order to comply with laws and regulations. The segments covered by the presentation are as follow:
Review federal criminal actions that can be imposed on a pharmacist when fraud and diversion of prescriptions for Schedules II through V controlled substances are detected through an investigation.
Identify the responsibilities and actions of DEA through their Diversion personnel to enforce federal laws and DEA regulations on the dispensing of a controlled substance by means of a prescription.
Discuss the steps that a pharmacist can use to determine the legitimacy of a prescription and when the pharmacist would need to discuss the necessity for the prescription and the individual treatment plan leading to the prescribing of a narcotic as part of a patient’s care.
Discuss the role of the Pharmacist and their responsibilities to develop and enforce a Due Diligence Policy in a pharmacy to prevent fraud or diversion of controlled substances obtained through a prescriptions.
Discuss the RED FLAG indicators for prescriptions written by a physician that may not be for a legitimate medical purpose. This section covers both the prescriber and the patient.
Review questions that can be asked by the pharmacist of the prescriber and patient in order to be in compliance with federal laws and DEA regulations. This section will also cover the Drug Trends that result in fraud and diversion of controlled substances obtained.
Who can Benefit:
Regulatory personnel including members of a state Board of Pharmacy or Department of Health.
Click here for more information
Live Session for one participant
Corporate Live Session 4 to 10 participants in single location.
Corporate Multi-Live Session 12 to 20 participants in single location.
Recorded Session Access recorded sessions only for one participant unlimited viewing for 6 months. (Access to recorded session will be sent after the completion of live session)